Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dumotier BM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Fundamental & Clinical Pharmacology; Jan1998, Vol. 12 Issue 1, p70-76, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dumotier BM; Novartis Biomedical Research, Translational Medicine, Preclinical Safety, Basel CH-4056, Switzerland. Electronic address: berengere.dumotier@novartis.com., Urban L; Novartis Biomedical Research, Translational Medicine, Preclinical Safety, Cambridge, MA 02139, United States.
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2024 Jul-Aug; Vol. 128, pp. 107542. Date of Electronic Publication: 2024 Jul 19.
Autor:
Sellner H; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Chapeau E; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Furet P; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Voegtle M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Salem B; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Le Douget M; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Bordas V; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Groell JM; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Le Goff AL; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Rouzet C; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Wietlisbach T; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Zimmermann T; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., McKenna J; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Brocklehurst CE; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Chène P; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Wartmann M; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Scheufler C; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Kallen J; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Williams G; Pharmacokinetics Sciences, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Harlfinger S; Pharmacokinetics Sciences, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Traebert M; Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Dumotier BM; Preclinical Safety, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Schmelzle T; Oncology Drug Discovery, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland., Soldermann N; Global Discovery Chemistry, Novartis Institutes for BioMedical Research, Basel, 4002, Switzerland.
Publikováno v:
ChemMedChem [ChemMedChem] 2023 Jun 01; Vol. 18 (11), pp. e202300051. Date of Electronic Publication: 2023 Apr 13.
Autor:
Dumotier BM
Publikováno v:
Postgraduate medical journal [Postgrad Med J] 2015 Apr; Vol. 91 (1074), pp. 221-9.
Autor:
Dumotier BM
Publikováno v:
Heart (British Cardiac Society) [Heart] 2014 Dec; Vol. 100 (24), pp. 1907-15. Date of Electronic Publication: 2014 Sep 02.
Autor:
Dumotier BM; PreClinical Safety, Novartis Pharma AG, Basel, Switzerland. berengere.dumotier@novartis.com, Deurinck M, Yang Y, Traebert M, Suter W
Publikováno v:
Pharmacology & therapeutics [Pharmacol Ther] 2008 Aug; Vol. 119 (2), pp. 152-9. Date of Electronic Publication: 2008 Mar 26.
Autor:
Guérard NC; Novartis Pharma Ag, Exploratory Development, Safety Pharmacology, Basel, Switzerland., Traebert M, Suter W, Dumotier BM
Publikováno v:
Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2008 Jul-Aug; Vol. 58 (1), pp. 32-40. Date of Electronic Publication: 2008 Jun 08.